Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | IT (& TMT) • Media • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Logistics (& Distribution) • Material Science |
Stages | Expansion, MBO/LBO, Acquisition, Recapitalization, Restructuring, Privatization |
Investing | Spain |
Assets Under Management | €1,000,000,000 |
Advent International Advisory, S.L. is a prominent private equity investment firm with headquarters located in Madrid, Spain. The firm specializes in various forms of equity investment, including Expansion, Management Buy-Outs/Management Buy-Ins (MBO/MBI), Acquisition, Recapitalization, Restructuring, and Privatization. With assets under management totaling approximately $1 billion, Advent International targets a wide range of industries including Information Technology and TMT (Technology, Media, Telecommunications), Media, Business Solutions, FinTech and Financial Services, Hardware and Manufacturing, HealthTech and Fitness, Logistics and Distribution, and Material Science. Emphasizing a partnership approach, the firm employs a comprehensive investment strategy that focuses on working closely with portfolio companies to drive growth and value creation. Their sector expertise is complemented by a global outreach, with operations in diverse geographies like Australia, Brazil, Colombia, France, Germany, Greater China, India, Italy, Luxembourg, Mexico, Spain, the United Kingdom, and the United States, which allows for a wide network of resources and opportunities for their investments. Furthermore, Advent International is dedicated to responsible investment practices, ensuring that their activities contribute positively to various stakeholders and the broader community. The firm’s portfolio reflects its commitment to pioneering services and driving innovation, as evident in their investment in Genoa Healthcare, a pharmacy service provider in the US. Advent International Advisory continues to share insights and strategies on helping drug companies improve their manufacturing of medicines effectively through their platform 'Ideas'.